LTS acquires Sorrel wearable injection device business
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Essex enriches and complements Emmes’ services
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Subscribe To Our Newsletter & Stay Updated